IONTOPHORESIS Versus Ultrasound in Mechanical Neck Pain

September 23, 2022 updated by: Hend Hamdy, Cairo University

Magnesium Sulphate Iontophoresis Versus High- Power Pain Threshold Ultrasound in Mechanical Neck Pain

to investigate the effects of Magnesium Sulphate Iontophoresis versus High Power Pain Threshold Ultrasound on pain, function and range of motion on active MTrPs found in the upper trapezius.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Myofascial pain syndrome (MPS) is a musculoskeletal chronic pain disorder that affects the majority of pain population and characterized by the presence of trigger points. MPS is usually associated with tenderness, spasm, movement limitation and referred pain .

Myofascial trigger points (MTrPs) are hyperirritable taut fibers of skeletal muscle. The taut fibers within the muscle create palpable nodules that may cause local pain, and refer pain elsewhere with soft tissue examination .

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Cairo, Egypt
        • Recruiting
        • Faculty of Physical Therapy Cairo University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 23 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subjects, with age ranged from 19-23 years (Forman et al, 2014) from both genders. The subjects had active MTrPs in the upper fibers of trapezius muscle.

Exclusion Criteria:

  • • History of whiplash injury.

    • History of cervical spine surgery.
    • Cervical radiculopathy or myelopathy.
    • Having undergone physical therapy within the past three months before the study.
    • Non- rheumatologic diseases as multiple sclerosis, thyroid dysfunction and chronic infection.
    • Rheumatologic condition as poly-articular osteoarthritis, rheumatoid arthritis and advanced cervical spine degenerative diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group (A)
Other: Magnesium Sulphate Iontophoresis +conventional therapy
will receive Mgso4 Iontophoresis in addition to conventional therapy twice a week/4 weeks
Other: conventional theapy
will receive postural correction exercise-stretching and strengthening twice a week/4weeks
Experimental: Group (B)
Other: conventional theapy
will receive postural correction exercise-stretching and strengthening twice a week/4weeks
Other: High- Power Pain Threshold Ultrasound +conventional therapy
will receive HPPT-US on the upper trapezius in addition to conventional therapy twice a week/4 weeks
Other: Group (c)
Other: conventional theapy
will receive postural correction exercise-stretching and strengthening twice a week/4weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: up to four weeks
The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain
up to four weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain pressure threshold (PPT)
Time Frame: up to four weeks
Pain pressure threshold (PPT) is used to measure deep muscular tissue sensitivity by Algometer.
up to four weeks
neck disability
Time Frame: up to four weeks
will be measured by Arabic neck disability index
up to four weeks
range of motion
Time Frame: up to four weeks
will be measured by myrin gravity reference goniometer
up to four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2022

Primary Completion (Anticipated)

October 1, 2022

Study Completion (Anticipated)

November 15, 2022

Study Registration Dates

First Submitted

July 23, 2022

First Submitted That Met QC Criteria

July 23, 2022

First Posted (Actual)

July 26, 2022

Study Record Updates

Last Update Posted (Actual)

September 27, 2022

Last Update Submitted That Met QC Criteria

September 23, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • p.T.RCE/012/003552

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Point Pain, Myofascial

Clinical Trials on Magnesium Sulphate Iontophoresis +conventional therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe